Targeting Metastatic Melanoma

被引：53

作者：

Flaherty, Keith T. ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA

来源：

ANNUAL REVIEW OF MEDICINE, VOL 63 | 2012年 / 63卷

关键词：

BRAF; vemurafenib; GSK2118436; MEK; CTLA-4; ULTRAVIOLET-RADIATION; BRAF; KINASE; MUTATIONS; RAF; INHIBITION; CANCER; CELLS; SUSCEPTIBILITY; EPIDEMIOLOGY;

D O I：

10.1146/annurev-med-050410-105655

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Metastatic melanoma has historically been one of the most treatment-refractory types of cancer. Recent headway has been made in understanding the genetic underpinnings of this cancer. A subset of oncogenic events is amenable to targeting with drug therapy. BRAF-targeted therapies represent the first major breakthrough in systemic therapy for melanoma leveraging the new genetic knowledge. Ongoing translational research seeks to identify the most scientifically rational combination treatment strategies to build on single-agent targeted therapy.

引用

页码：171 / 183

页数：13

共 53 条

[31]

Long GV, 2010, ANN ONCOL, V21, P12

[32] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[33]

Marais R, 1996, CANCER SURV, V27, P101

[34] Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation [J].

Nazarian, Ramin ;

Shi, Hubing ;

Wang, Qi ;

Kong, Xiangju ;

Koya, Richard C. ;

Lee, Hane ;

Chen, Zugen ;

Lee, Mi-Kyung ;

Attar, Narsis ;

Sazegar, Hooman ;

Chodon, Thinle ;

Nelson, Stanley F. ;

McArthur, Grant ;

Sosman, Jeffrey A. ;

Ribas, Antoni ;

Lo, Roger S. .

NATURE, 2010, 468 (7326) :973-U377

[35] Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy [J].

Paraiso, K. H. T. ;

Fedorenko, I. V. ;

Cantini, L. P. ;

Munko, A. C. ;

Hall, M. ;

Sondak, V. K. ;

Messina, J. L. ;

Flaherty, K. T. ;

Smalley, K. S. M. .

BRITISH JOURNAL OF CANCER, 2010, 102 (12) :1724-1730

[36] PTEN Loss Confers BRAF Inhibitor Resistance to Melanoma Cells through the Suppression of BIM Expression [J].

Paraiso, Kim H. T. ;

Xiang, Yun ;

Rebecca, Vito W. ;

Abel, Ethan V. ;

Chen, Y. Ann ;

Munko, A. Cecilia ;

Wood, Elizabeth ;

Fedorenko, Inna V. ;

Sondak, Vernon K. ;

Anderson, Alexander R. A. ;

Ribas, Antoni ;

Dalla Palma, Maurizia ;

Nathanson, Katherine L. ;

Koomen, John M. ;

Messina, Jane L. ;

Smalley, Keiran S. M. .

CANCER RESEARCH, 2011, 71 (07) :2750-2760

[37] Timing of excessive ultraviolet radiation and melanoma:: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma [J].

Pfahlberg, A ;

Kölmel, KF ;

Gefeller, O .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (03) :471-475

[38] Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma [J].

Phan, GQ ;

Yang, JC ;

Sherry, RM ;

Hwu, P ;

Topalian, SL ;

Schwartzentruber, DJ ;

Restifo, NP ;

Haworth, LR ;

Seipp, CA ;

Freezer, LJ ;

Morton, KE ;

Mavroukakis, SA ;

Duray, PH ;

Steinberg, SM ;

Allison, JP ;

Davis, TA ;

Rosenberg, SA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8372-8377

[39] RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF [J].

Poulikakos, Poulikos I. ;

Zhang, Chao ;

Bollag, Gideon ;

Shokat, Kevan M. ;

Rosen, Neal .

NATURE, 2010, 464 (7287) :427-U126

[40] Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4 [J].

Prickett, Todd D. ;

Agrawal, Neena S. ;

Wei, Xiaomu ;

Yates, Kristin E. ;

Lin, Jimmy C. ;

Wunderlich, John R. ;

Cronin, Julia C. ;

Cruz, Pedro ;

Rosenberg, Steven A. ;

Samuels, Yardena .

NATURE GENETICS, 2009, 41 (10) :1127-U112

← 1 2 3 4 5 6 →